Furthermore, it is possible that β-catenin acts as a molecular toggle, with high levels (as seen in CRC) repressing MUC4 and low to moderate levels (as seen in pancreatic cancer) promoting MUC4 transcription via a differential recruitment of co-factors. The gene discussed is MUC4; the disease is pancreatic neoplasm.